Prime Therapeutics LLC, a pharmacy benefit manager owned by members of the Blue Cross Blue Shield insurance network, was hit Friday with federal antitrust claims in Los Angeles over its alleged decision to slash pharmacy reimbursement rates as part of an agreement with a rival.
The collaboration between Prime and
Prime didn’t immediately respond to a request for comment Friday. ESI isn’t named as a defendant.
PBMs ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.